JP

Jayshree Pramodbhai Patel

Active Director Designated Partner DIN 09442963
DIN 09442963 First appointment Dec 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Jayshree Pramodbhai Patel

Data last updated:

Jayshree Pramodbhai Patel is a Designated Partner at Kaival Pathology Laboratory Llp (since 2021). The company operates in Healthcare.

DIN 09442963
Primary Designation Designated Partner
Industry Healthcare
First Appointment 21 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Dec 20212021Active

Board colleagues of Jayshree Pramodbhai Patel

NameDINCompanyDesignation
Mukeshkumar Shankarbhai Patel09442952Kaival Pathology Laboratory LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Kaival Pathology Laboratory Llp
Premium access

Shareholding and investment profile for Jayshree Pramodbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayshree Pramodbhai Patel

Jayshree Pramodbhai Patel currently holds 1 directorship: Kaival Pathology Laboratory Llp (Designated Partner, since 21 Dec 2021).

Jayshree Pramodbhai Patel was first appointed on 21 Dec 2021 as Designated Partner at Kaival Pathology Laboratory Llp.

The current boards of Jayshree Pramodbhai Patel's companies include Mukeshkumar Shankarbhai Patel (Kaival Pathology Laboratory Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available